![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, June 30, 2023 12:46:39 AM
![Bullish](/static/images/ih2-bull.png)
Recent QNRX News
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/12/2024 08:32:25 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:01:28 PM
- Quoin Pharmaceuticals Provides Corporate Update and Announces Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 08/08/2024 12:30:00 PM
- Quoin Pharmaceuticals to Initiate Clinical Study for Peeling Skin Syndrome • GlobeNewswire Inc. • 08/06/2024 09:00:00 AM
- Quoin Pharmaceuticals to Announce Second Quarter 2024 Financial Results on Thursday, August 8, 2024 • GlobeNewswire Inc. • 08/01/2024 08:10:00 PM
- Quoin Pharmaceuticals Announces International Expansion of Ongoing Clinical Trials for Netherton Syndrome • GlobeNewswire Inc. • 06/27/2024 12:00:00 PM
- Quoin Pharmaceuticals to Sponsor the Foundation for Ichthyosis & Related Skin Types (FIRST) 2024 National Conference • GlobeNewswire Inc. • 06/25/2024 08:05:00 PM
- Quoin Pharmaceuticals Announces Signing of Research Agreement with University College Cork (UCC), Ireland • GlobeNewswire Inc. • 06/12/2024 12:00:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/10/2024 08:10:54 PM
- Quoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/09/2024 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/08/2024 08:00:53 PM
- Quoin Pharmaceuticals to Announce First Quarter 2024 Financial Results on May 9, 2024 • GlobeNewswire Inc. • 05/02/2024 08:10:00 PM
- Quoin Pharmaceuticals Provides Corporate Update and Announces Fourth Quarter and 2023 Financial Results • GlobeNewswire Inc. • 03/13/2024 08:05:00 PM
- Mixed Futures Amidst Quiet Economic Schedule; Oil Prices Climb • IH Market News • 03/13/2024 11:03:39 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/08/2024 09:06:10 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/08/2024 09:04:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 09:01:51 PM
- Quoin Pharmaceuticals Announces Fourth Quarter and 2023 Financial Results and Corporate Update Conference Call to be held on Thursday March 14th at 8:30 am ET • GlobeNewswire Inc. • 03/07/2024 09:05:00 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 03/06/2024 10:07:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:01:40 PM
- Quoin Pharmaceuticals Announces Pricing of $6.5 Million Public Offering • GlobeNewswire Inc. • 03/05/2024 01:00:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/04/2024 10:27:14 PM
- Quoin Pharmaceuticals Announces FDA Clearance to Recruit Teen Subjects into Both Ongoing Netherton Syndrome Clinical Studies • GlobeNewswire Inc. • 03/04/2024 01:00:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 02/27/2024 11:01:59 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/15/2024 05:15:38 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM
All Things Mobile Analytic, Inc. Reports Major Growth with Over $11 Million in Revenue • ATMH • Aug 22, 2024 7:19 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM